Brief: Astrazeneca Pharma India Gets Nod In Form CT-20 To Import For Sale And Distribution Of Trastuzumab Deruxtecan (Enhertu) 100mg/5ml Vial Lyophilized Powder
03/05/2023 14:21
May 3 (Reuters) - Astrazeneca Pharma India Ltd
ASTR.NS :
* ASTRAZENECA PHARMA INDIA LTD - RECEIVED PERMISSION IN FORM
CT-20
TO IMPORT FOR SALE AND DISTRIBUTION OF TRASTUZUMAB DERUXTECAN
(ENHERTU) 100MG/5ML VIAL LYOPHILIZED POWDER
Source text for Eikon: ID:nBSE7fh8qT
Further company coverage: ASTR.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Astrazeneca Pharma India
See all newsBrief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan
India's Astrazeneca Pharma logs worst slide in two months on quarterly profit drop
Brief: Astrazeneca Pharma India March-Quarter PAT 448.8 Million Rupees
Brief: Astrazeneca Pharma India Recommends Dividend Of 36 Rupees Per Equity Share For Fy2025-26
Brief: Astrazeneca Pharma India Receives Permission To Import Durvalumab (Imfinzi) For Additional Indication